Andy Slavitt, Biden's senior Covid advisor, says he will likely be leaving the White Home in early June
Tom Williams | CQ Roll Call, Inc. | Getty Images
Andy Slavitt, a senior advisor to President Joe Biden's coronavirus response team, confirmed on Friday that he will be leaving his role in early June.
Slavitt, whose temporary position on Biden's Covid panel is known to expire next month, said that while the government had achieved many of its goals for the pandemic, there was more work to be done.
"Look, there's never a perfect time to go," Slavitt said in a Bloomberg interview. But he said he believes that by the time he leaves, "things are in really good hands with the people here, that many difficult things have been accomplished."
"There's a lot more to do, but the people here, I couldn't think of a better group than the people who will be here when I'm gone," he said.
When asked what still needs to be done, Slavitt mentioned the "big job" of convincing the remaining block of unvaccinated Americans to get their shots and helping other struggling nations to vaccinate.
"There will always be things to do, there will always be challenges," said Slavitt. "Hopefully, for the sake of the country, they won't be as intense as before."
Slavitt said he would be leaving sometime "early June". The White House did not respond to CNBC's request for comment for further details. Slavitt was a so-called special employee of the government, a status that, according to the Interior Ministry, limited his service to 130 days.
Slavitt discussed his plans a day after the Centers for Disease Control and Prevention announced that fully vaccinated people would no longer need to wear masks in most situations.
The change in guidelines meant a significant relaxation of the social distancing recommendations that were in place in one form or another during most of the pandemic. Biden and other government officials hailed the update, which coincided with the US reaching 250 million vaccinations, as a turning point in the United States' fight against the virus.